News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
209 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42567)
2024 (37443)
2025 (33092)
2026 (4936)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Business
Debt-Ridden Teva Considers Cutting Up to 10,000 Jobs
Teva may be passing out more pink slips as the company looks to cut up to 10,000 jobs in order to save up to $2B in costs over the next two years.
December 11, 2017
·
2 min read
·
Alex Keown
Business
Merck Laying Off 50 Employees in North Carolina
Layoffs are expected to begin in February, according to reports.
December 11, 2017
·
2 min read
·
Alex Keown
Genetown
Top 5 Massachusetts Biotechs That Jumped at Least 250% in 2017
Boston Business Journal pulled together a list of the 25 biggest gainers in the state for 2017, and five of them are biopharma companies.
December 11, 2017
·
4 min read
·
Mark Terry
Business
Poached From AstraZeneca, New Pharma Head Looks to Resuscitate GlaxoSmithKline’s Cancer Pipeline
GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.
December 11, 2017
·
1 min read
Job Trends
New York’s Koning Picks Atlanta for New HQ, Will Create Up to 400 New Jobs
Koning has selected Atlanta for its new headquarters and intends to open a new 100,000 square foot facility there.
December 11, 2017
·
2 min read
·
Alex Keown
Business
Intuitive Surgical Pays $274M to Goldman Sach, Closes $2B Share Buyback Deal
The payback was part of a total $3 billion stock repurchasing deal the company initiated on January 27.
December 11, 2017
·
1 min read
FDA
Why a FDA Approval for an Accessory Could be a Huge Deal for Apple
This could be the first step in a long journey that could amount to huge profitability for the iPhone maker.
December 11, 2017
·
1 min read
Business
Mako Medical to Create 153 Jobs in North Carolina Expansion
The expansion will nearly double its employment.
December 11, 2017
·
2 min read
·
Alex Keown
Deals
China Investor Syndicate Acquires Esaote, an Italian Imaging Device Company
Esaote S.p.A., an Italian medical imaging company, has been acquired by a group of China investors.
December 11, 2017
·
1 min read
Business
Week in Review: China Life Science Deals Total $550M
Pfizer acquired China/Asia rights for Cresemba, an antifungal drug developed by Swiss pharma Basilea, in a $226M deal.
December 11, 2017
·
1 min read
1 of 21
Next